XML 18 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss), Net of Income Tax
Common stock, issued and treasury, beginning balance (in shares) at Jun. 30, 2021   68,069,321        
Common stock, treasury, beginning balance (in shares) at Jun. 30, 2021     (8,751,377)      
Common stock, outstanding, beginning balance (in shares) at Jun. 30, 2021   59,317,944        
Stockholder's equity, beginning balance at Jun. 30, 2021 $ 1,400,936 $ 681 $ (222,530) $ 432,550 $ 1,187,728 $ 2,507
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 182,820       182,820  
Other comprehensive income (loss) (4,133)         (4,133)
Stock-based compensation expense and restricted stock unit vesting, issued (in shares)   548,089        
Share-based compensation expense and restricted stock unit vesting, treasury stock (in shares)     (203,238)      
Stock-based compensation expense and restricted stock unit vesting, outstanding (in shares)   344,851        
Stock-based compensation activity 5,962 $ 5 $ (9,921) 15,878    
Common stock, issued and treasury, ending balance (in shares) at Mar. 31, 2022   68,617,410        
Common stock, treasury, ending balance (in shares) at Mar. 31, 2022     (8,954,615)      
Common stock, outstanding, ending balance (in shares) at Mar. 31, 2022   59,662,795        
Stockholder's equity, ending balance at Mar. 31, 2022 1,585,585 $ 686 $ (232,451) 448,428 1,370,548 (1,626)
Common stock, issued and treasury, beginning balance (in shares) at Dec. 31, 2021   68,376,837        
Common stock, treasury, beginning balance (in shares) at Dec. 31, 2021     (8,878,262)      
Common stock, outstanding, beginning balance (in shares) at Dec. 31, 2021   59,498,575        
Stockholder's equity, beginning balance at Dec. 31, 2021 1,523,157 $ 684 $ (228,657) 441,061 1,308,725 1,344
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 61,823       61,823  
Other comprehensive income (loss) (2,970)         (2,970)
Stock-based compensation expense and restricted stock unit vesting, issued (in shares)   240,573        
Share-based compensation expense and restricted stock unit vesting, treasury stock (in shares)     (76,353)      
Stock-based compensation expense and restricted stock unit vesting, outstanding (in shares)   164,220        
Stock-based compensation activity 3,575 $ 2 $ (3,794) 7,367    
Common stock, issued and treasury, ending balance (in shares) at Mar. 31, 2022   68,617,410        
Common stock, treasury, ending balance (in shares) at Mar. 31, 2022     (8,954,615)      
Common stock, outstanding, ending balance (in shares) at Mar. 31, 2022   59,662,795        
Stockholder's equity, ending balance at Mar. 31, 2022 $ 1,585,585 $ 686 $ (232,451) 448,428 1,370,548 (1,626)
Common stock, issued and treasury, beginning balance (in shares) at Jun. 30, 2022 68,859,722 68,859,722        
Common stock, treasury, beginning balance (in shares) at Jun. 30, 2022 (9,081,773)   (9,081,773)      
Common stock, outstanding, beginning balance (in shares) at Jun. 30, 2022 59,777,949 59,777,949        
Stockholder's equity, beginning balance at Jun. 30, 2022 $ 1,642,973 $ 689 $ (237,011) 453,784 1,428,444 (2,933)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 219,809       219,809  
Other comprehensive income (loss) (2,640)         (2,640)
Purchase of treasury stock (in shares)   (849,081) (849,081)      
Purchase of treasury stock (31,605)   $ (31,605)      
Stock-based compensation expense and restricted stock unit vesting, issued (in shares)   480,811        
Share-based compensation expense and restricted stock unit vesting, treasury stock (in shares)     (54,555)      
Stock-based compensation expense and restricted stock unit vesting, outstanding (in shares)   426,256        
Stock-based compensation activity $ 15,567 $ 5 $ (3,587) 19,149    
Common stock, issued and treasury, ending balance (in shares) at Mar. 31, 2023 69,340,533 69,340,533        
Common stock, treasury, ending balance (in shares) at Mar. 31, 2023 (9,985,409)   (9,985,409)      
Common stock, outstanding, ending balance (in shares) at Mar. 31, 2023 59,355,124 59,355,124        
Stockholder's equity, ending balance at Mar. 31, 2023 $ 1,844,104 $ 694 $ (272,203) 472,933 1,648,253 (5,573)
Common stock, issued and treasury, beginning balance (in shares) at Dec. 31, 2022   69,153,591        
Common stock, treasury, beginning balance (in shares) at Dec. 31, 2022     (9,153,512)      
Common stock, outstanding, beginning balance (in shares) at Dec. 31, 2022   60,000,079        
Stockholder's equity, beginning balance at Dec. 31, 2022 1,787,559 $ 692 $ (239,941) 465,350 1,568,403 (6,945)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 79,850       79,850  
Other comprehensive income (loss) 1,372         1,372
Purchase of treasury stock (in shares)   (849,081) (849,081)      
Purchase of treasury stock (31,605)   $ (31,605)      
Stock-based compensation expense and restricted stock unit vesting, issued (in shares)   186,942        
Share-based compensation expense and restricted stock unit vesting, treasury stock (in shares)     17,184      
Stock-based compensation expense and restricted stock unit vesting, outstanding (in shares)   204,126        
Stock-based compensation activity $ 6,928 $ 2 $ (657) 7,583    
Common stock, issued and treasury, ending balance (in shares) at Mar. 31, 2023 69,340,533 69,340,533        
Common stock, treasury, ending balance (in shares) at Mar. 31, 2023 (9,985,409)   (9,985,409)      
Common stock, outstanding, ending balance (in shares) at Mar. 31, 2023 59,355,124 59,355,124        
Stockholder's equity, ending balance at Mar. 31, 2023 $ 1,844,104 $ 694 $ (272,203) $ 472,933 $ 1,648,253 $ (5,573)